CSIMarket


COVIDIEN LTD.  (COV)
Other Ticker:  
 

Covidien Ltd's

Competitiveness


 

COV Sales vs. its Competitors Q4 2014



Comparing the results to its competitors, Covidien Ltd reported Total Revenue increase in the 4 quarter 2014 by 1.78 % year on year.
The revenue growth was below Covidien Ltd's competitors average revenue growth of 9.42 %, recorded in the same quarter.

List of COV Competitors

With net margin of 19.02 % company achieved higher profitability than its competitors.

More on COV Margin Comparisons



Revenue Growth Comparisons




Net Income Comparison


COVIDIEN LTD. Net Income in the 4 quarter 2014 grew year on year by 28.39 %, slower than its competitors income growth of 63.33 %

<<  More on COV Income Comparisons


Covidien Ltd's Comment on Competitors and Industry Peers


We participate in medical device and medical supply markets around the world. These global markets are characterized by continuous change resulting from technological innovations. Our market position depends on our ability to develop and commercialize products that meet clinician needs, while offering reliable product quality, cost-effectiveness and dependable service. Both the medical device and medical supply markets are highly competitive.

There is no single company that competes with us over the full breadth of products offered by our Medical Devices segment. Competitors of our Medical Devices segment include diversified healthcare companies, such as Johnson & Johnson, Boston Scientific, Baxter and C.R. Bard, and other companies that are more focused on specific product categories, such as Masimo and Dräger. Our Medical Supplies segment competes against branded products offered by Becton Dickinson and C.R. Bard, as well as private-label products provided by low-cost suppliers, such as Cardinal Health and Medline. While customers may choose our medical supply products based on reputation for quality, they may turn to products from low-cost suppliers.





  

Overall company Market Share Q4 2014

Overall company revenue, grew with moderate pace of 1.78 % slower than competitors within this segment.

<<  More on COV Market Share.
 

*Market share calculated with total revenue.


COV's vs. Competition, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
COVIDIEN LTD. 10,880 0 1,605 39,500
3m Company 35,326 101,190 5,979 89,800
Abbott Laboratories 42,308 233,053 7,244 77,000
Biogen Inc 11,101 33,275 2,106 7,550
General Electric Company 75,754 103,507 -109 305,000
Amgen Inc 32,341 115,391 5,609 17,900
Becton Dickinson And Company 20,248 70,715 2,092 30,619
0 0 0 0
Boston Scientific Corporation 11,469 56,649 1,155 24,000
Bard C R Inc 5,308 28,675 690 13,900
Cardinal Health Inc 167,370 13,589 1,137 34,500
Gilead Sciences Inc 27,482 87,785 7,369 7,000
Johnson and Johnson 91,446 426,326 17,880 126,500
Mckesson Corporation 250,991 34,067 -4,618 70,400
MEDIMMUNE, INC. 0 0 0 0
Medtronic Plc 31,797 144,841 4,731 49,000
Patterson Companies Inc 6,377 2,873 159 7,000
Bristol Myers Squibb Co 45,468 126,189 -5,385 25,000
Pfizer Inc 69,337 310,696 19,239 78,300
SCHERING-PLOUGH CORPORATION 0 0 0 0
Varian Medical Systems Inc 3,118 16,326 277 6,800
Intuitive Surgical Inc 5,489 117,974 1,709 2,978
Danaher Corporation 28,065 227,507 5,885 71,000
Kimberly clark Corporaton 19,311 45,682 2,029 57,000
Carefusion Corp 3,556 0 368 16,000
Roper Technologies Inc 6,084 49,730 1,121 10,137
Merck and Co Inc 49,150 186,080 7,211 70,000
Stryker Corp 16,669 94,477 1,900 26,000
Thermo Fisher Scientific Inc 39,059 252,536 8,565 51,000
Helen Of Troy Limited 2,164 5,848 215 1,610
Darling Ingredients Inc 4,451 10,794 546 10,000
Osi Systems inc 1,171 1,629 84 0
SUBTOTAL 1,113,289 2,897,402 96,792 1,325,494


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

QFTA's Profile

Stock Price

QFTA's Financials

Business Description

Fundamentals

Charts & Quotes

QFTA's News

Suppliers

QFTA's Competitors

Customers & Markets

Economic Indicators

QFTA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071